<DOC>
	<DOCNO>NCT00209703</DOCNO>
	<brief_summary>We perform feasibility study mFOLFOX6 advance colorectal cancer Japan estimate safety efficacy regimen .</brief_summary>
	<brief_title>Feasibility Study mFOLFOX6 Patients With Advanced Colorectal Cancer</brief_title>
	<detailed_description>A multicenter Open-label , single-arm feasibility study conduct patient histological stage IV colorectal cancer give oxaliplatin , leucovorin plus fluorouracil . The usefulness regimen therapy colorectal cancer evaluate disease-free survival rate ( DFR ) , overall survival rate ( OS ) , incidence severity adverse event .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>1 . Histological diagnosis colorectral adenocarcinoma . 2 . Measurable assessable lesion . 3 . Age : 15 ~ 75 year . 4 . Performance Status ( ECOG ) : 0 ~ 2 . 5 . Prior chemotherapy within 2 regimen . 6 . Adequate function major organ ( bone marrow , heart , lung , liver etc. ) . WBC 3,500/mm3 . Hb 10.0 g/dl . Platelet count 100,000/mm3 . GOT GPT 2.5times upper limit normal ( exclude liver metastasis ) . TBil 3.0mg/dl . Creatinine within upper limit normal . Normal ECG ( consider clinically unimportant arrhythmias ischemic change ) . ( 10 ) Predicted survival &gt; 8 week . ( 11 ) Able give write informed consent . 1 . Severe pleural effusion ascites . 2 . Metastasis central nervous system ( CNS ) . 3 . Active gastrointestinal bleeding . 4 . Active infection . 5 . Uncontrolled ischemic heart disease . 6 . Serious complication ( intestinal paralysis , intestinal obstruction , interstitial pneumonia pulmonary fibrosis , uncontrolled diabetes mellitus , heart failure , renal failure , hepatic failure ) . 7 . Active multiple cancer . 8 . Severe mental disorder . 9 . Pregnancy , possible pregnancy , breastfeed . 10 . Patients neuropathy â‰¥ grade 2 11 . Judged ineligible protocol attend physician .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2006</verification_date>
</DOC>